Stock Market Live May 5, 2026: S&P 500 (SPY) Bounces on Pullback in Oil

Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Chris Lange | Jun 19, 2017 at 11:10 AM EDT

Rigel Pharma Rises Following FDA Approval

Rigel Pharmaceuticals watched its shares make a handy uptick on Monday after the FDA approved its New Drug Application for…

Chris Lange | Jun 19, 2017 at 10:20 AM EDT

Is This the Buyout Novadaq Needs?

Novadaq Technologies watched its shares practically double to kick off the week after the firm announced that it would be…

Chris Lange | Jun 19, 2017 at 9:00 AM EDT

Clovis Oncology Surges on Clutch Late-Stage Ovarian Cancer Trial

Clovis Oncology saw its shares make a massive gain early on Monday after the company announced top-line data from its…

Chris Lange | Jun 16, 2017 at 10:45 AM EDT

Aurinia Pharma Rises Following Updated Mid-Stage Results

Shares of Aurinia Pharmaceuticals saw a handy gain on Friday after the firm presented new data from its mid-stage study…

Chris Lange | Jun 16, 2017 at 8:50 AM EDT

Mersana Therapeutics Closes in on IPO After Announcing Expected Price Range

Mersana Therapeutics expects to price its 5 million shares in the range of $14 to $16 apiece in an initial…

Chris Lange | Jun 14, 2017 at 10:05 AM EDT

Aldeyra Stumbles Over Mid-Stage Clinical Results

Aldeyra Therapeutics saw its shares slide on Wednesday after the company said its allergic conjunctivitis drug missed the primary endpoint…

Chris Lange | Jun 14, 2017 at 9:15 AM EDT

Alexion Pharmaceuticals Adds New CFO From Biogen

Shares of Alexion Pharmaceuticals saw a handy gain early on Wednesday after the company announced that there would be changes…

Chris Lange | Jun 13, 2017 at 1:15 PM EDT

How Omeros Won Big on This FDA Approval

Omeros saw its shares make a handy gain on Tuesday after the company announced that the FDA granted a Breakthrough…

Chris Lange | Jun 13, 2017 at 9:10 AM EDT

Acceleron Pharma Slides on Missed Mid-Stage Results

Acceleron Pharma saw its shares droop early on Tuesday after the firm offered an update from its mid-stage trial in…

Chris Lange | Jun 12, 2017 at 11:25 AM EDT

Why Coherus Biosciences Shares Are Crashing

Coherus Biosciences saw its shares crater on Monday after the company announced that it received a complete response letter from…

Lee Jackson | Jun 12, 2017 at 10:10 AM EDT

4 Red-Hot Pharmaceutical and Biotechs Highlight Jefferies Top Stocks to Buy

A series of new reports from Jefferies focus on some of the top stocks in the pharmaceutical and biotech arenas.…

Chris Lange | Jun 12, 2017 at 9:40 AM EDT

Short Interest Surges in Major Biotechs

The May 31 short interest data have been compared with the previous report, and short interest in most of the…

Chris Lange | Jun 12, 2017 at 8:55 AM EDT

Short Sellers Grow More Selective on Major Pharma

The May 31 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | Jun 9, 2017 at 10:30 AM EDT

Who Wins From Endo’s Opana Getting Pulled From the Market

In an unprecendented move, the U.S. Food and Drug administration (FDA) requested that Endo International remove its Opana ER from…

Chris Lange | Jun 9, 2017 at 10:10 AM EDT

FDA Shelves Endo Pharma Amid Opioid Abuse

In an unprecedented move, the FDA has requested that Endo International remove its opioid pain medication from the market. The…

1 … 163 164 165 166 167 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Rigel Pharma Rises Following FDA Approval

Is This the Buyout Novadaq Needs?

Clovis Oncology Surges on Clutch Late-Stage Ovarian Cancer Trial

Aurinia Pharma Rises Following Updated Mid-Stage Results

Mersana Therapeutics Closes in on IPO After Announcing Expected Price Range

Aldeyra Stumbles Over Mid-Stage Clinical Results

Alexion Pharmaceuticals Adds New CFO From Biogen

How Omeros Won Big on This FDA Approval

Acceleron Pharma Slides on Missed Mid-Stage Results

Why Coherus Biosciences Shares Are Crashing

4 Red-Hot Pharmaceutical and Biotechs Highlight Jefferies Top Stocks to Buy

Short Interest Surges in Major Biotechs

Short Sellers Grow More Selective on Major Pharma

Who Wins From Endo’s Opana Getting Pulled From the Market

FDA Shelves Endo Pharma Amid Opioid Abuse

Stock Market Live May 5, 2026: S&P 500 (SPY) Bounces on Pullback in Oil

Live Nasdaq Composite: Tech Stock Gains Unleashed as Stars Align for Risk-On Trade

These 4 Dividend Growers Have Already Declared 10% Dividend Increases

Analysts See 118% Upside for Strategy After Bitcoin Crashed 27% in 6 Months

A Bigger 2027 Capex Wave May Be Coming — and Google’s Hint Could Be the First Real Tell From the Hyperscalers

27% of Americans Own ETFs but Allocate Just 6%, Here's Why That Costs Them Retirement Income

Seven Out of Every Ten Dollars of Americans $18.8 Trillion Debt Is Tied To A House

These 4 Dividend Growers Have Already Declared 10% Dividend Increases

Analysts See 118% Upside for Strategy After Bitcoin Crashed 27% in 6 Months

Health and Healthcare Articles

All Health and Healthcare Articles

Rigel Pharma Rises Following FDA Approval

Is This the Buyout Novadaq Needs?

Clovis Oncology Surges on Clutch Late-Stage Ovarian Cancer Trial

Aurinia Pharma Rises Following Updated Mid-Stage Results

Mersana Therapeutics Closes in on IPO After Announcing Expected Price Range

Aldeyra Stumbles Over Mid-Stage Clinical Results

Alexion Pharmaceuticals Adds New CFO From Biogen

How Omeros Won Big on This FDA Approval

Acceleron Pharma Slides on Missed Mid-Stage Results

Why Coherus Biosciences Shares Are Crashing

4 Red-Hot Pharmaceutical and Biotechs Highlight Jefferies Top Stocks to Buy

Short Interest Surges in Major Biotechs

Short Sellers Grow More Selective on Major Pharma

Who Wins From Endo’s Opana Getting Pulled From the Market

FDA Shelves Endo Pharma Amid Opioid Abuse

Stock Market Live May 5, 2026: S&P 500 (SPY) Bounces on Pullback in Oil

Live Nasdaq Composite: Tech Stock Gains Unleashed as Stars Align for Risk-On Trade

These 4 Dividend Growers Have Already Declared 10% Dividend Increases

Analysts See 118% Upside for Strategy After Bitcoin Crashed 27% in 6 Months

A Bigger 2027 Capex Wave May Be Coming — and Google’s Hint Could Be the First Real Tell From the Hyperscalers

Featured Reads

27% of Americans Own ETFs but Allocate Just 6%, Here's Why That Costs Them Retirement Income

Seven Out of Every Ten Dollars of Americans $18.8 Trillion Debt Is Tied To A House